Reaching for the unreasonable
Nightingale’s technology was born out of the pioneering vision of combining low-cost and high-tech. From the start, Nightingale’s blood analysis was designed to enable extensive biomarker profiling on a global scale. This transformational mindset is the core of the company.
By bringing extensive biological data to routine blood testing, Nightingale aims to transform preventive medicine in chronic diseases.
Nightingale serves world-leading universities globally, and will enter the clinical market in the very near future. The company’s headquarters, R&D facilities and analysis laboratories are located in Finland.